Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masakazu Toi

Showing results (31-40 of 536) with videos related to

Pageof 54
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2005
[Basic fibroblast growth factor]Hiroyasu Yamashiro, Masakazu Toi
The Lancet. Oncology|September 1, 2023
SERDs for primary breast cancerMasakazu Toi, Tomoyuki Aruga
Japanese Journal of Clinical Oncology|January 30, 2014
Antiangiogenesis therapy for breast cancer: an update and perspectives from clinical trialsElham Fakhrejahani, Masakazu Toi
Journal of Oncology|October 19, 2011
Tumor angiogenesis: pericytes and maturation are not to be ignoredElham Fakhrejahani, Masakazu Toi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2009
[Anti-HER2 antibody and small-molecule tyrosine kinase inhibitor therapy targeting EGFR signal pathway]Hiroyasu Yamashiro, Masakazu Toi
Advances in Experimental Medicine and Biology|May 13, 2021
Next-Generation Clinical Trials and Research with Successful CollaborationsMasakazu Toi, Ravi Velaga
Breast Cancer (Tokyo, Japan)|November 25, 2016
Antitumor immunity and advances in cancer immunotherapyTomoharu Sugie, Masakazu Toi
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
Comments to the Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines 2022Masakazu Toi, Masahiro Takada
Expert Opinion on Emerging Drugs|July 2, 2005
Aromatase inhibitors and other novel agents in breast cancer treatmentShigehira Saji, Masakazu Toi
Breast Cancer (Tokyo, Japan)|January 29, 2008
Molecular target therapy: basics and clinical applicationShinzaburo Noguchi, Masakazu Toi
Pageof 54

Showing results (31-40 of 536) with videos related to

Sort By:
Pageof 54
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2005
[Basic fibroblast growth factor]Hiroyasu Yamashiro, Masakazu Toi
The Lancet. Oncology|September 1, 2023
SERDs for primary breast cancerMasakazu Toi, Tomoyuki Aruga
Japanese Journal of Clinical Oncology|January 30, 2014
Antiangiogenesis therapy for breast cancer: an update and perspectives from clinical trialsElham Fakhrejahani, Masakazu Toi
Journal of Oncology|October 19, 2011
Tumor angiogenesis: pericytes and maturation are not to be ignoredElham Fakhrejahani, Masakazu Toi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2009
[Anti-HER2 antibody and small-molecule tyrosine kinase inhibitor therapy targeting EGFR signal pathway]Hiroyasu Yamashiro, Masakazu Toi
Advances in Experimental Medicine and Biology|May 13, 2021
Next-Generation Clinical Trials and Research with Successful CollaborationsMasakazu Toi, Ravi Velaga
Breast Cancer (Tokyo, Japan)|November 25, 2016
Antitumor immunity and advances in cancer immunotherapyTomoharu Sugie, Masakazu Toi
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
Comments to the Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines 2022Masakazu Toi, Masahiro Takada
Expert Opinion on Emerging Drugs|July 2, 2005
Aromatase inhibitors and other novel agents in breast cancer treatmentShigehira Saji, Masakazu Toi
Breast Cancer (Tokyo, Japan)|January 29, 2008
Molecular target therapy: basics and clinical applicationShinzaburo Noguchi, Masakazu Toi
Pageof 54